167 related articles for article (PubMed ID: 33357715)
1. Editorial: Cardiovascular and renal 2020: Cardiovascular protection by antidiabetic drugs: Key mechanisms and current clinical data.
Gorr MW; Wold LE
Curr Opin Pharmacol; 2020 Oct; 54():vii-ix. PubMed ID: 33357715
[No Abstract] [Full Text] [Related]
2. [Cardiovascular protection of patients with type 2 diabetes : from EMPA-REG OUTCOME to LEADER].
Scheen AJ; Wallemacq C; Jandrain B; Ernest P
Rev Med Suisse; 2016 Aug; 12(527):1370-1375. PubMed ID: 28671791
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and hypertension: a comprehensive report on management and the prevention of cardiovascular and renal complications.
Handelsman Y
J Clin Hypertens (Greenwich); 2011 Apr; 13(4):221-3. PubMed ID: 21466616
[No Abstract] [Full Text] [Related]
4. Spotlight on Antidiabetic Agents with Cardiovascular or Renoprotective Benefits.
Madievsky R
Perm J; 2018; 22():18-034. PubMed ID: 30227909
[TBL] [Abstract][Full Text] [Related]
5. Results from Cardiovascular Outcome Trials in Diabetes.
Muñoz Torres M; Muñoz Garach A
Endocrinol Nutr; 2016; 63(7):317-9. PubMed ID: 27324936
[No Abstract] [Full Text] [Related]
6. SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.
Bell RM; Yellon DM
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):435-437. PubMed ID: 29030201
[No Abstract] [Full Text] [Related]
7. Preventing Cardiovascular Disease in Patients With Diabetes: New Evidence Informs Changes in Standards of Care.
Worel JN; Hayman LL
J Cardiovasc Nurs; 2016; 31(3):198-200. PubMed ID: 27058859
[No Abstract] [Full Text] [Related]
8. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
9. The reno-cardiovascular connection in the patient with Diabetes mellitus: What's new?
Palau V; Riera M; Soler MJ
Endocrinol Diabetes Nutr; 2017 May; 64(5):237-240. PubMed ID: 28495318
[No Abstract] [Full Text] [Related]
10. What to treat? The structural basis for renal and vascular complications and hypertension, and the role of angiotensin converting enzyme inhibition. Symposium, 26th meeting of the European Association for the Study of Diabetes. Dublin, Ireland, 10 September 1991.
J Hypertens Suppl; 1992 Apr; 10(1):S1-53. PubMed ID: 1619498
[No Abstract] [Full Text] [Related]
11. Guidelines for When to Consider Mortality-Reducing Treatments for Patients With Type 2 Diabetes Mellitus.
Shaughnessy AF
Am Fam Physician; 2022 Jan; 105(1):93. PubMed ID: 35029952
[No Abstract] [Full Text] [Related]
12. SGLT-2 inhibitors in diabetes: a focus on renoprotection.
Gonzalez DE; Foresto RD; Ribeiro AB
Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s17-s24. PubMed ID: 31939531
[TBL] [Abstract][Full Text] [Related]
13. [Early insulin therapy reduces cardiovascular risk].
Med Monatsschr Pharm; 2007 Apr; 30(4):160-1. PubMed ID: 17484451
[No Abstract] [Full Text] [Related]
14. Research digest: more cardiovascular outcome trials in diabetes.
Sattar N; Preiss D
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):687. PubMed ID: 28802986
[No Abstract] [Full Text] [Related]
15. Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetes.
Miao Y; Smink PA; de Zeeuw D; Lambers Heerspink HJ
Clin Chem; 2011 Feb; 57(2):186-95. PubMed ID: 21159899
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Toft E; Rydén M
Lakartidningen; 2018 Feb; 115():. PubMed ID: 29461566
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of some antidiabetic drugs.
Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745
[No Abstract] [Full Text] [Related]
18. Hyperglycaemia in diabetes: impact on nephropathy and cardiac risk.
Torffvit O
Nephrol Dial Transplant; 2003 Sep; 18(9):1711-5. PubMed ID: 12937215
[No Abstract] [Full Text] [Related]
19. Glycemic management of type 2 diabetes: how tight is right and how to get there.
Nathan DM
Arch Intern Med; 2008 Oct; 168(19):2064-6. PubMed ID: 18955633
[No Abstract] [Full Text] [Related]
20. Cardiovascular and renal disease in untreated and treated hypertension.
Mancia G; Giannattasio C; Pozzi M
Contrib Nephrol; 1994; 109():65-9. PubMed ID: 7956231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
